CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1133-1142

  Sepulveda, Homero ^a,c   Cerwenka, Adelheid ^b,d   Morgan, Tammy ^b   Dutton, Richard W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TRUDEAU INSTITUTE   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; DRUG SYNERGISM; FLUORESCEINS; FLUORESCENT DYES; H-Y ANTIGEN; INDICATORS AND REAGENTS; INTERLEUKIN-2; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, SCID; MICE, TRANSGENIC; PROPIDIUM; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; SUCCINIMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033179402     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science 950:1042.
2. Lafferty, K. J., S. J. Prowse, C. J. Simeonovic, and H. S. Warren. 1983. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol. 1:143.
3. Jenkins, M. K., D. M. Pardoll, J. Mizuguchi, H. Quill, and R. H. Schwartz. 1987. T-cell unresponsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state. J. Exp. Med. 165:302.
4. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
5. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
6. + T cells independently of the CD28/B7 and LFA-I/ICAM-1 costimulatory interactions. J. Immunol. 160:3180.
7. Luxembourg, A. T., A. B., Brunmark, Y. Kong, M. R. Jackson, P. A. Peterson, J. Sprent, and Z. Cai. 1998. Requirements for stimulating naive CD8 T cells via signal one alone. J. Immunol. 161:5226.
8. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
9. Freeman, G. J., G. S. Gray, C. D. Gimmi, D. B. Lombard, L. J. Zhou, M. White, J. D. Fingeroth, J. G. Gribben, and L. M. Nadler. 1991. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174:625.
10. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
11. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, J. G. Gribben, J. W. Ng, J. Kim, J. M. Goldberg, K. Hathcock, G. Laszlo, et al. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:2185.
12. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, K. S. Hathcock, G. Laszlo, A. J. McKnight, J. Kim, L. Du, D. B. Lombard, et al. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907.
13. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restive, Jr., L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
14. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
15. Ranger, A. M., M. P. Das, V. K. Kuchroo, and L. H. Glimcher. 1996. B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int. Immunol. 8:1549.
16. June, C. H., J. A. Ledbetter, P. S. Linsley, and C. B. Thompson. 1990. Role of the CD28 receptor in T-cell activation. Immunol. Today 11:211.
17. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
18. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897.
19. Byrne, J. A., J. L. Butler, E. L. Reinherz, and M. D. Cooper. 1989. Virgin and memory T cells have different requirements for activation via the CD2 molecule. Int. Immunol. 1:29.
20. Kato, K., M. Koyanagi, H. Okada, T. Takanashi, Y. W. Wong, A. F. Williams, K. Okumura, and H. Yagita. 1992. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J. Exp. Med. 176:1241.
21. Holter, W., M. Schwarz, A. Cerwenka, and W. Knapp. 1996. The role of CD2 as a regulator of human T-cell cytokine production. Immunol. Rev. 153:107.
22. Bowen, M. A., R. K. Lee, G. Miragliotta, S. Y. Nam, and E. R. Podack. 1996. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156:442.
23. Grewal, I. S., and R. A. Flavell. 1996. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153:85.
24. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862.
25. Liu, Y., B. Jones, A. Aruffo, K. M. Sullivan, P. S. Linsley, and C. A. Janeway, Jr. 1992. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med. 175:437.
26. Liu, Y., B. Jones, W. Brady, C. A. Janeway, Jr., P. S. Linsley, and P. S. Linley. 1992. Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur. J. Immunol. 22:2855.
27. Liu, Y., R. H. Wenger, M. Zhao, and P. J. Nielsen. 1997. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185:25.
28. Goodwin, R. G., W. S. Din, T. D. Smith, D. M. Anderson, S. D. Gimpel, T. A. Sato, C. R. Maliszewski, C. I. Brannan, N. G. Copeland, N. A. Jenkins, et al. 1993. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23:2631.
29. Pollok, K. E., Y. J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-IBB: analysis of expression and function. J. Immunol. 150:771.
30. DeBenedette, M. A., A. Shahinian, T. W. Mak, and T. H. Watts. 1997. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J. Immunol. 158:551.
31. Williams, J. M., D. Deloria, J. A. Hansen, C. A. Dinarello, R. Loertscher, H. M. Shapiro, and T. B. Strom. 1985. The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64. 1) monoclonal antibody and purified interleukin I. J. Immunol. 135:2249.
32. Houssiau, F. A., P. G. Coulie, D. Olive, and J. Van Snick. 1988. Synergistic activation of human T cells by interleukin 1 and interleukin 6. Eur. J. Immunol. 18:653.
33. Houssiau, F. A., P. G. Coulie, and J. Van Snick. 1989. Distinct roles of IL-1 and IL-6 in human T cell activation. J. Immunol. 143:2520.
34. Vink, A., C. Uyttenhove, P. Wauters, and J. Van Snick. 1990. Accessory factors involved in murine T cell activation: distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor. Eur. J. Immunol. 20:1.
35. + T cells to immobilized anti-TCR monoclonal antibody. J. Immunol. 152:1618.
36. Joseph, S. B., K. T. Minor, and M. Croft. 1998. Augmentation of naive, Th1 and Th2 effect CD4 response by IL-6, IL-1 and TNF. Eur. J. Immunol. 28:277.
37. Vella, A. T., T. Mitchell, B. Groth, P. S. Linsley, J. M. Green, C. B. Thompson, J. W. Kappler, and P. Marrack. 1997. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J. Immunol. 158:4714.
38. + T cells by transforming growth factor-β1. J. Immunol. 151:668.
39. Kuhlman, P., V. T. Moy, B. A. Lollo, and A. A. Brian. 1991. The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation: contributions of adhesion and co-activation. J. Immunol. 146:1773.
40. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155:45.
41. Dubey, C., and M. Croft. 1996. Accessory molecule regulation of naive CD4 T cell activation. Immunol. Res. 15:114.
42. + T cells. Proc. Natl. Acad. Sci. USA 93:14736.
43. + T cells. Eur. J. Immunol. 27:598.
44. + T cells. J. Immunol. 158:637.
45. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
46. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
47. Harding, F., and J. Allison. 1993. CD28-B7 interactions allow the induction of CD8 cytotoxic lymphocytes in the absense of exogenous help. J. Exp. Med. 177:1791.
48. Norton, S. D., L. Zuckerman, K. B. Urdahl, R. Shefner, J. Miller, and M. K. Jenkins. 1992. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. J. Immunol. 149:1556.
49. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
50. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
51. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
52. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
53. Chambers, C. A., M. F. Krummel, B. Boitel, A. Hurwitz, T. J. Sullivan, S. Fournier, D. Cassell, M. Brunner, and J. P. Allison. 1996. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 153:27.
54. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1996. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol. Rev. 153:5.
55. Sperling, A. I., and J. A. Bluestone. 1996. The complexities of T-cell co-stimulation: CD28 and beyond. Immunol. Rev. 153:155.
56. Waterhouse, P., L. E. Marengere, H. W. Mittrucker, and T. W. Mak. 1996. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 153:183.
57. + T cells. Immunol. Rev. 177: 213.
58. Valle, A., J. P. Aubry, I. Durand, and J. Banchereau. 1991. IL-4 and IL-2 up-regulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions. Int. Immunol. 3:229.
59. Sperling, A. I., J. A. Auger, B. D. Ehst, I. C. Rulifson, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 interactions deliver a uniques signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.
60. Sagerstrom, C. G., E. M. Kerr, J. P. Allison, and M. M. Davis. 1993. Activation and differentiation requirements of primary T cells in vitro. Proc. Natl. Acad. Sci. USA 90:8987.
61. Dubey, C., M. Croft, and S. L. Swain. 1996. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157:3280.
62. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
63. Horak, I. 1996. Interleukin-2-knockout mice: a new model to study autoimmunity and self-tolerance. Sb. Lek. 97:25.
64. . Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
65. Cerwenka, A., L. L. Carter, J. B. Reome, S. L. Swain, and R. W. Dutton. 1998. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 161:97.
66. + T cells in vitro. J. Exp. Med. 183:2247.
67. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
68. Willerford, D., J. Chen, J. Ferry, L. Davidson, A. Ma, and F. Alt. 1995. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
69. + T-helper and T-killer cell. Nature 393:474.
70. Bennett, S. R. M., F. R. Carbone, F. Karamlis, R. A. Flavell, J. F. A. P. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478.
71. Schoenberger, S. P., R. E. M. Toes, E. I. H. Van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.